Navigation Links
Singulex Teams With Wyeth Pharmaceuticals to Translate Pre-Clinical Biomarker Research Into Clinical Study Design
Date:11/27/2007

HAYWARD, Calif., Nov. 27 /PRNewswire/ -- Singulex Inc. today announced that it is collaborating with researchers at Wyeth Research to develop immunoassays on the company's Erenna(TM) system. Singulex has installed the Erenna system at Wyeth as part of its Erenna Technology Access Program (ETAP) and has begun optimizing assays that will allow Wyeth to accurately and precisely measure specific biomarkers in human blood.

"Biomarkers play an important role in the evaluation of compounds in both drug discovery and development, and we are keenly interested in applying new and improved technologies in the measurements of biomarkers," said Ole Vesterqvist, Ph.D., senior director of the Biomarker Laboratory in Clinical Translational Medicine at Wyeth. "For example, with the right biomarker and technology, one can study the effects of a therapeutic intervention in clinical studies. However, many biomarkers are present in human blood at extremely low concentrations, making it difficult to accurately and precisely measure. Singulex has provided us with a new technology for detection of biomarkers at very low concentrations and we are currently validating several assays in our laboratory that should help us guide our clinical programs."

Singulex's proprietary advanced biomarker detection technologies and optimized immunoassays are incorporated into Erenna, the company's flagship biomarker detection platform system. Erenna and accompanying assays are designed to measure very low levels and small changes of protein biomarkers across a variety of biological samples from multiple species. Singulex was the first to identify and quantify normal levels and small changes of cardiac troponin I, a protein biomarker used to detect cardiotoxicity and heart attacks, in human plasma.

"Singulex's technology extends the clinical utility of new and existing biomarkers by removing the limits of detection," said Philippe Goix, Ph.D., president and CEO of Singulex. "The
'/>"/>

SOURCE Singulex Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Bacteria from sponges make new pharmaceuticals
2. Researchers develop liquid crystal pharmaceuticals to fight cancer and other diseases
3. NMR researchers unlock hydrogens secrets to spot polymorphism in pharmaceuticals
4. A search for biomarkers for early detection of colorectal cancer
5. Research shows skeleton to be endocrine organ
6. Newly created cancer stem cells could aid breast cancer research
7. Dominant cholesterol-metabolism ideas challenged by new research
8. Researchers identify proteins involved in new neurodegenerative syndrome
9. Texas researchers and educators head for Antarctica
10. MGH researchers describe new way to identify, evolve novel enzymes
11. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... affordable health care to reproductive technologies, the justice ... ability of people to identify key issues, articulate ... and find the most defensible ways forward. But ... these societal conversations?, The Hastings Center and the ... have teamed up to publish a series of ...
(Date:9/17/2014)... student have designed a device based on a shorebird,s ... dew., The device could provide water in drought-stricken areas ... Luo, professor in the Mechanical & Aerospace Engineering Department, ... of Engineering department, published "Bioinspired Plate-Based Fog Collectors" in ... Applied Materials & Interfaces journal. ...
(Date:9/17/2014)... developed, very cleverly, some lessons on how to create ... Joseph Shaw, director of the Optical Technology Center at ... at the nanoscale, we,ll discover them." , Some of ... during a conference called "The Nature of Light: Light ... the University of Arizona College of Optical Sciences. The ...
Breaking Biology News(10 mins):Why bioethics literacy matters 2Why bioethics literacy matters 3Shorebird's beak inspires UT Arlington research on water collection 2Nature's designs inspire research into new light-based technologies 2Nature's designs inspire research into new light-based technologies 3
... Institute have deciphered the structure of the active region ... in the development of nearly all human cancers. The ... new, broadly effective cancer drugs, as well as anti-aging ... decade to find drugs that shut down telomerasewidely considered ...
... the Alliance for a Healthier Generation and the American ... such as soft drinks at schools. However, researchers at ... soft drinks at school may not be enough to ... a study of more than 4,000 children, the researchers ...
... during cardiac procedures. Doctors performing heart surgery also face ... is helping to raise awareness of threats, through training ... imaging systems. The issue of radiation protection for ... lengthy angioplasty and other cardiac interventions performed under X-ray ...
Cached Biology News:Landmark study opens door to new cancer, aging treatments 2Landmark study opens door to new cancer, aging treatments 3Protecting those who heal 2
(Date:9/18/2014)... 2014 September 24 marks ASEA's "Meet ... is the manufacturer of the world's first and only ... RENU28. , The Mexico City event features renowned ... and ASEA Field Leader Shawn Catmull from Draper, UT. ... Atomic/Medical Physics from the University of Utah and devotes ...
(Date:9/17/2014)... A long-term retrospective study of breast ... via interstitial brachytherapy suggests that women younger than ... be suitable to receive the treatment. Current American ... patients in the "unsuitable" category for APBI. In ... Beaumont Health System,s Peter Y. Chen , ...
(Date:9/17/2014)... 17, 2014  The In Silico Drug Discovery Conference ... featured at the conference, which takes place at North ... and 4, 2014. Researchers, students, drug developers, business development ... following: KEYNOTE SPEAKERS ... School of Pharmacy Drug Discovery with Three ...
(Date:9/17/2014)... , Sept. 17, 2014  MiMedx Group, Inc. (NASDAQ: ... and marketer of patent protected regenerative biomaterials and ... publication of another peer-reviewed clinical study.    ... Multi-center Randomized Controlled Clinical Trial Evaluating the Use ... Allografts and Multi-layer Compression Therapy vs. Multi-layer Compression ...
Breaking Biology Technology:Announcing the ASEA Mexico Grand Opening Tour Beginning September 18th 2Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable 2Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable 3Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable 4In Silico Drug Discovery Conference Announces Speakers and Topics 2In Silico Drug Discovery Conference Announces Speakers and Topics 3In Silico Drug Discovery Conference Announces Speakers and Topics 4In Silico Drug Discovery Conference Announces Speakers and Topics 5In Silico Drug Discovery Conference Announces Speakers and Topics 6In Silico Drug Discovery Conference Announces Speakers and Topics 7MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 2MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 3MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 4
... LIVINGSTON and PARSIPPANY, N.J., Jan. 20, 2012 Columbia ... Pharmaceuticals, Inc. (NYSE: WPI ), today confirmed ... the U.S. Food and Drug Administration (FDA) did not ... reduction of risk of preterm birth in women with ...
... Boulder Diagnostics Inc. and Portland State University (PSU) ... agreement to develop rapid diagnostic tests for homocysteine and ... developed at PSU. Under the agreement Boulder will finance ... will be entitled to royalties on future sales of ...
... Mellon University researchers have discovered that an element commonly found ... lethal effects of a compound known as Shiga toxin. New ... by Carnegie Mellon biologists Adam Linstedt and Somshuvra Mukhopadhyay ... models. Produced by certain bacteria, including ...
Cached Biology Technology:FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length 2FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length 3FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length 4FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length 5Boulder Diagnostics Licenses Novel Rapid Detection Technology for Homocysteine and Related Compounds from Portland State University 2Carnegie Mellon study reveals potential of manganese in neutralizing deadly Shiga toxin 2Carnegie Mellon study reveals potential of manganese in neutralizing deadly Shiga toxin 3Carnegie Mellon study reveals potential of manganese in neutralizing deadly Shiga toxin 4
...
TNM-FH Insect Medium 1 liter...
IHC Polymer Detection Kit (Rabbit DAB)150 slides...
Performance, mycoplasma, virus, and endotoxin tested. Collected from calves 14 days old or less...
Biology Products: